From the first launch to ongoing market access operational execution, IntegriChain solves some of the most complex and pressing challenges associated with drug commercialization. We deliver pharma’s only comprehensive data, consulting, and business process platform for market access departments, providing the strategy, data, applications, and infrastructure for therapy commercialization.
Solutions overview
IntegriChain delivers the pharmaceutical industry’s largest and only data and business process platform for therapy commercialization and access. Manufacturers rely on our analytics, applications, and managed services to power their operations and harness the value of their channel, patient and payer data.
View all products
IntegriChain provides a complete set of professional services for commercialization and market access execution–from life science strategy and operational consulting to implementation, integration, migrations, and analytics.
Services overview
We help all stakeholders in the pharmaceutical industry drive access with our relentless focus on unifying all of the critical business functions for therapy commercialization and access – contracts & pricing, gross-to-net, channel, and patient services – to unlock strategic payer, provider, pharmacy and patient access insights.
Learn more about our company
Learn more about joining our growing IntegriChain team of data scientists, market access experts, analysts, and consulting professionals – our culture, our purpose, our teams in the US and Pune. Check out our careers or keep in touch for future opportunities.
Careers overview
December 6, 2021
Philadelphia, PA, December 6, 2021 – IntegriChain, delivering Life Sciences’ only comprehensive data and business process platform for market access, today announced that channel data expert and Vice President of Industry Solutions Dave Weiss will present the latest distributor inventory and service level benchmarks, including trend data on alternative channel design, at Informa’s upcoming Trade and Channel Strategies conference. Weiss has extensive experience in channel and patient data, traditional and alternative channel design, market access, and commercialization. IntegriChain is a sponsor of the conference, which runs December 13-17, 2021, at the Hilton at Penn’s Landing in Philadelphia.
Weiss’ session during the conference is as follows.
The State of the Channel 2021 and the Emergence of Alternative Channel Designs Monday, December 13, 9:15 am ET In this session, Weiss will present benchmark data on the current state of trade and distribution, including wholesale/distribution and downstream inventories and service level trends. He will also review trends in 867 data redaction and its implications on network design and data strategy. In addition, he will present alternative channel design trends and benchmarks focusing on so-called “spectail” or “specialty light” brands.
About IntegriChain’s Channel Data Products IntegriChain offers a full suite of channel data products, including:
Channel Data Aggregation: Aggregation of all channel and distribution datasets including ExFactory Sales, Distributor Inventories, Demand, and Returns to deliver the highest quality master data.
Refined Channel Data: Employs industry-leading data science and enrichment algorithms to deliver end-to-end views of product distribution. Refined Channel Data includes two datasets: National and Subnational. Both datasets offer 100% visibility to all gross and net downstream sales including both direct and indirect sales, returns to morgue, and returns to inventory.
Inventory Analytics: Manufacturers have few existing measures of the inventory held in retail stores, distribution centers, and third-party returns processors. IntegriChain Inventory Analytics reports 100% of inventory in the retail channel, even in pharmacy stores and distribution centers that do not report their inventories.
Distribution Contract Management: Distribution Contract Management is a single, auditable application for managing all aspects of trade partner agreements. Configurable trade partner scorecard functionality features payment adjudication, custom pay-for-performance metrics, payment roll forward, and top- and bottom-line functionality adjustments.
Channel Data Consulting Services: Based on IntegriChain pioneering the field of channel data aggregation, stewardship, and advanced analytics, the Channel Insights and Optimization practice delivers Market Demand Analysis, Class of Trade, Downstream Inventory Analytics, Returns Forecasting, and Revenue Analytics consulting services to Life Sciences manufacturers of all types and sizes.
About IntegriChain IntegriChain is Life Sciences’ data and application backbone for patient access and therapy commercialization. More than 250 manufacturers rely on IntegriChain’s ICyte Platform to orchestrate commercial and government payer contracting, patient services, and distribution channels. ICyte is the first and only platform that unites the financial, operational, and commercial data sets required to support therapy access in the era of specialty and precision medicine. With ICyte, Life Sciences innovators are digitalizing labor-intensive processes – freeing up their best talent to identify and resolve coverage and availability hurdles and to manage pricing and forecasting complexity. IntegriChain is backed by Accel-KKR, a leading Silicon Valley technology private equity firm. The company is headquartered in Philadelphia, PA, with offices in Ambler, PA; Raleigh, NC, and Pune, India. For more information, visit www.integrichain.com, or follow us on Twitter @IntegriChain and LinkedIn.
Contact Jennifer Guinan, Sage Strategic Marketing, 610.410.8111, Jennifer@sagestrat.com
Save the date!
Webinars & Resources
See List
